Back to Top Skip to main content Skip to sub-navigation

DoD Establishes Collaborative Virus Genetic Sequencing Capability for COVID-19

Image of two scientists in masks looking at a computer monitor Research associate Lindsay Glang and senior bioinformatics analyst Gregory Rice sequencing SARS-CoV-2 genomes on Oxford Nanopore MinION platform at NMRC BDRD. (Photo Courtesy of Naval Medical Research Center, Genomics & Bioinformatics Department.)

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus | Global Emerging Infections Surveillance

As the pandemic continues to unfold, genetic sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), has played a critical role in the public health response, including in the design of diagnostics and vaccines. Within the Department of Defense, SARS-CoV-2 genetic sequence data plays a vital role in force health protection efforts.

To jumpstart the DoD’s SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance (GEIS) section used its existing partnerships with Army, Navy, and Air Force public health and medical research laboratories. This connection helped to establish a collaborative approach to the sequencing capabilities. Sequence data from this collaboration will provide critical information about transmission patterns, track diagnostic effectiveness, and guide the development and evaluation of medical countermeasures for the 1.4 million active duty and 331,000 reserve personnel.

“GEIS-funded surveillance provides near-real time understanding of how the SARS-CoV-2 virus is evolving. This information is critical for the development of a vaccine and treatment,” stated Navy Capt. Guillermo Pimentel, GEIS chief. “Previous investments by GEIS in this technology have given our partners the capability to respond and sequence SARS-CoV-2 genomes isolated from DoD Service members around the world.”

In 2017, GEIS established a Next Generation Sequencing and Bioinformatics Consortium to work with GEIS partner DoD laboratories to coordinate and improve pathogen sequencing and analysis efforts around the world. Consortium partners can rapidly detect and characterize known, emerging, and novel infectious disease agents using data from pathogen sequencing. This helps to inform force health protection decision making. The core Consortium partners include: the Naval Medical Research Center (NMRC), U.S. Army Medical Research Institute of Infectious Diseases, Walter Reed Army Institute of Research, U.S. Air Force School of Aerospace Medicine, and the Naval Health Research Center.

“We have used virus sequence data in numerous studies to track virus transmission [such as dengue and influenza],” said Irina Maljkovic Berry, chief of Viral Genetics and Emerging Diseases for the WRAIR Viral Diseases Branch in Silver Spring, Maryland. “We estimate outbreak origins to detect and track vaccine escape and other important mutations throughout the world to aid in vaccine design.”

Consortium partners played a key role in analyzing previous viral outbreaks, such as Ebola in West Africa and Zika in South America, and in seasonal influenza vaccine selection. "Each year we generate thousands of influenza genomes that we use to determine how influenza is evolving or evading our vaccines which directly impact our forces," said Clarise Starr, deputy chief of Pathogen Detection and Therapeutics Portfolio Applied Technology and Genomics Division, U.S. Air Force School of Aerospace Medicine. "These efforts will be the same essential practices that we'll need to deploy in response to SARS-CoV-2."

This open partnership and investment proved extremely helpful in response to the COVID-19 pandemic. DoD laboratories quickly established the ability to isolate the virus, share samples, and compare laboratory methods to improve their sequencing capabilities. “We have been evaluating a few different laboratory sequencing protocols to determine which one works best for samples with certain attributes, in order help increase the efficiency of SARS-CoV-2 sequencing from swabs,” according to Kimberly Bishop-Lilly, head of Genomics & Bioinformatics Department at NMRC in Fort Detrick, Maryland.

The sequence data that's being collected is a valuable source of information to better understand virus transmission patterns among DoD personnel, particularly when combined with other clinical and epidemiological data. These data are also compared to global virus sequence data.

“The goal is to have data and information that could help answer how local outbreaks may have started, how SARS-CoV-2 may have spread in a community or geographic area, and how we can better contain spread or improve interventions,” said Lindsay Morton, GEIS’s senior molecular epidemiologist. Thus far, SARS-CoV-2 sequence data has been gathered from infected personnel at more than 25 locations across the globe.

Additionally, GEIS partners are leveraging this technology to improve understanding of global circulation of SARS-CoV-2 through surveillance programs at DoD overseas labs, such as in Thailand, Peru, Kenya, and Cambodia.

“The OCONUS (Outside Continental United States) labs are starting to stand up SARS-CoV-2 sequencing capabilities and the core labs of the Consortium are providing them reach-back support for sequencing protocols and for bioinformatics analyses,” said Bishop-Lilly. “Consensus viral genomes are being produced at some of the OCONUS labs and we are comparing to viral genomes obtained from samples in other regions such as the U.S., to identify what lineage is predominant in a given geographic region and what key genetic variations may be predominant in a certain area.”

These data will provide a better understanding of transmission in these locations and result in a better understanding of risk to U.S. forces deployed around the world as the COVID-19 pandemic continues. GEIS leaders hope that increased collaboration across the agencies will propel the research and production of an effective vaccine.

“The key to fully utilizing SARS-CoV-2 sequence data is collaboration,” said Morton, “Consortium partners are ready and willing to engage with organizations involved with clinical studies and outbreak investigations across the DoD to better guide the Department’s response to COVID-19 and reduce the impact to readiness and operations around the world.”

You also may be interested in...

Frontline Indiana Guardsmen receive COVID-19 vaccination

Article
12/18/2020
Soldier getting a vaccine in his left arm

These Guardsmen are trained medics who also took Centers for Disease Control and Prevention courses specific to the coronavirus.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance | Coronavirus and the COVID-19 Vaccine

Defense Health Agency Director: Vaccine rollout safe and effective

Article
12/18/2020
Image of military personnel giving a vaccine to a soldier in her right arm. Click to open a larger version of the image.

“In the coming months as the vaccine becomes more widely available, we strongly encourage everyone to get this vaccine,” Place stressed.

Recommended Content:

MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

CDC provides COVID-19 vaccine best practices for healthcare providers

Article
12/17/2020
Medical personnel filling a syringe from a vaccine bottle

[T]he Defense Health Agency’s Immunization Healthcare Division (IHD) is working in collaboration with the CDC to offer the training to the Military Health System’s health care providers.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance | Coronavirus and the COVID-19 Vaccine

Top five digital health trends for military medical providers in 2021

Article
12/17/2020
Image of Dr. Pincus with text "Top Five Digital Health Trends for Military Medical Providers in 2021"

One way the MHS will provide...improved care is through DoD’s new electronic health record MHS GENESIS, which will continue its rollout through 2023.

Recommended Content:

Coronavirus | Electronic Health Record: MHS GENESIS

COVID-19 surge spurs readiness efforts at Brooke Army Medical Center

Article
12/17/2020
Two hospital personnel, wearing masks, looking at a computer screen

Equipped with lessons learned, BAMC is preparing to shift resources and personnel to ensure hospital readiness in the event of a patient increase.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine

DHA contributes to COVID-19 vaccine effort

Article
12/16/2020
Vaccine bottles

While Pfizer’s vaccine is being distributed to all U.S. jurisdictions for administration, several more candidates are in development and clinical trials continue to be conducted simultaneously with pharmaceutical partners.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus and the COVID-19 Vaccine

Frontline health care workers among first in DOD for COVID-19 vaccine

Article
12/15/2020
Image of a man getting a vaccine. Click to open a larger version of the image.

"This is a very important day, not just for the Department of Defense, but for our nation," Miller said before getting his vaccination.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 Vaccine Headed to NMC San Diego and NH Camp Pendleton

Article
12/15/2020
Gloved hands preparing vaccine for transportation

[T]he first doses of the vaccine will be given to frontline health care workers and first responders, including emergency medical services personnel, security forces, and other essential personnel.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 Convalescent plasma collection continues

Article
12/14/2020
Three units of CCP laying on a table

CCP has a one-year shelf life, so collected units will begin to expire in 2021.

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Coronavirus and the COVID-19 Vaccine | Armed Services Blood Program

National Guard and Reservists doing their part to fight COVID-19

Article
12/14/2020
Military personnel performing nasal swabs of people in a row of cars

“We can do a thousand tests in just a couple hours,” Keller said. It was an example of ingenuity taking place all over the country, with members of the Military Health System partnering with civilian hospitals and clinics.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Hepburn: DOD role in Operation Warp Speed was ‘transformative’

Article
12/11/2020
Medical technician getting a syringe ready to give a vaccine

The FDA announced on Dec. 8 that its review of the Pfizer vaccine found it to be safe and efficacious.

Recommended Content:

COVID-19 Vaccine Efforts | Vaccine Trials | Coronavirus | Coronavirus and the COVID-19 Vaccine

DOD Officials Announce Distribution Plan for Initial COVID-19 Vaccine

Article
12/10/2020
Image of Mr. McCaffery speaking at a podium at the Pentagon

DOD is expected to receive around 44,000 doses of the Pfizer vaccine in the initial phase.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

Deputy defense secretary stresses team approach in battling COVID

Article
12/10/2020
Soldier wearing mask, standing at computer monitors in an office building

The Military Health System has played an important role implementing the National Defense Strategy, Norquist said.

Recommended Content:

Military Health System Transformation | Coronavirus | COVID-19 Vaccine Efforts | Health Readiness | Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine

MHS leaders discuss future of military medicine during AMSUS panel

Article
12/9/2020
Military personnel, wearing masks, standing in a line in front of flags

For Dingle, readiness is the key issue during the transition.

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Military Health System Transformation

DOD Announces COVID-19 Vaccine Distribution Plan

Article
12/9/2020
Soldier wearing mask, sitting in front of computer monitors

The Department prioritizes DOD personnel to receive the vaccine based on CDC guidance.

Recommended Content:

Public Health | Coronavirus | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine
<< < ... 6 7 8 9 10  ... > >> 
Showing results 136 - 150 Page 10 of 27

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.